A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 19271 participants.

Also called NCT01991795

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 19,271 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01991795
Other papers using this trial's data
  • Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis Journal of the American College of Cardiology, 2024-04-30 DOI, PubMed 38658101

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong SAR China, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Puerto Rico, Romania, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Türkiye, Ukraine, United Kingdom, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01991795. Randomized; quadruple masking; primary purpose prevention. Start 2014-02-10 (actual); primary completion 2019-01-25 (actual). Results posted on 2020-03-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Acronym
THEMIS
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Ticagrelor 60 mg
Intervention (Drug)
Ticagrelor placebo
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01991795
Content hash
e4f0fe4157a45848550bd044a9a0ae8d96868fccf589d0f893b85f897e07e8a2